Better target the tumor and its immune environment to defeat multiple myeloma
The ARC Foundation awarded a grant of 400,000 euros to Professor Hervé Avet-Loiseau for his work on multiple myeloma, the second most common malignant hemopathy (blood cancer), with more than 4,000 new cases every year. in France.
Please discover here the press release on the ARC Foundation’s website.